首页> 美国卫生研究院文献>BMC Proceedings >Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial

【2h】

Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial

机译：高活性抗逆转录病毒治疗（HAART）的早期（2周）与晚期（8周）开始可显着提高严重免疫抑制的HIV感染的新诊断结核病成年人的存活率：CAMELIA临床试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 BMC Proceedings
作者
François-Xavier Blanc; Thim Sok; Didier Laureillard; Laurence Borand; Claire Rekacewicz; Eric Nerrienet; Yoann Madec; Olivier Marcy; Sarin Chan; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeurn Hak; Bunnet Dim; Chhun Im Sin; Sath Sun; Bertrand Guillard; Borann Sar; Sirenda Vong; Marcelo Fernandez; Lawrence Fox; Jean-François Delfraissy; Anne E Goldfeld;
展开▼
作者单位

展开▼
年(卷),期 2011(5),Suppl 1
年度 2011
页码 O11
总页数 2
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献

1. Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial [J] . Fran?ois-Xavier Blanc, Thim Sok, Didier Laureillard, BMC proceedings. . 2011,第S1期

机译：高活性抗逆转录病毒治疗（HAART）的早期（2周）与晚期（8周）开始可显着提高严重免疫抑制的HIV感染的新诊断结核病成年人的存活率：CAMELIA临床试验的结果
2. Correction to Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial [Lancet Infect Dis, 14, (2014) 563-71] [J] . HaywardP. The Lancet infectious diseases . 2014,第9期

机译：对新诊断为肺结核的HIV阳性成年人进行高活性抗逆转录病毒治疗的早期和延迟启动的校正（TB-HAART）：一项前瞻性，国际，随机，安慰剂对照试验[Lancet Infect Dis，14，（2014）563- 71]
3. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial [J] . MfinangaS.G., KirengaB.J., ChandaD.M., The Lancet infectious diseases . 2014,第7期

机译：对于新诊断出的肺结核的HIV阳性成人（TB-HAART），应尽早开始或积极开展高活性抗逆转录病毒疗法：一项前瞻性，国际，随机，安慰剂对照试验
4. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis [O] . Lifang Li, Jianqiang Li, Chunwei Chai, 2021

机译：CD4 T细胞计数和抗逆转录病毒治疗炎症症炎症综合征和艾滋病毒感染成年人的全因死亡率的抗逆转录病毒治疗患者的优化时序与新诊断的肺结核系统审查和荟萃分析
5. Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial [O] . François-Xavier Blanc, Thim Sok, Didier Laureillard, 2011

机译：高活性抗逆转录病毒治疗（HAART）的早期（2周）与晚期（8周）相比，可显着提高严重免疫抑制的HIV感染的新诊断结核病成年人的存活率：CAMELIA临床试验的结果

Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial

著录项

相似文献

相关主题

期刊订阅